Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1970 Dec 12;4(5736):639–644. doi: 10.1136/bmj.4.5736.639

Outcome of Recent Thromboembolic Occlusions of Limb Arteries Treated with Streptokinase

A Amery, W Deloof, J Vermylen, M Verstraete
PMCID: PMC1820239  PMID: 5488380

Abstract

All our patients with a recent thromboembolic occlusion of limb arteries treated with streptokinase have been reviewed retrospectively. Clearing of the main artery, as judged by arteriography or reappearance of arterial pulsations, occurred more often when treatment was started early. If only patients with an iliac, femoral, or popliteal artery occlusion are considered, those who received a lower initial dose had a significantly higher clearing rate and a significantly lower mortality than those who received a high initial dose (500,000 units of streptokinase or more). Therefore an initial standard dose of 1,200,000 units of streptokinase is no longer recommended in these conditions, and even an individually titrated initial dose of more than half a million units could be hazardous. If no neurological abnormalities were present on admission amputation was never necessary, even if clearing of the main artery did not occur. If there was sensory loss of at least part of a limb, amputation was avoided only if the pulsations returned in at least one artery of hand or foot.

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMERY A., MAES H., VERMYLEN J., VERSTRAETE M. The streptokinase reactivity test. I. Standardization. Thromb Diath Haemorrh. 1963 Apr 15;9:175–188. [PubMed] [Google Scholar]
  2. COTTON L. T., FLUTE P. T., TSAPOGAS M. J. Popliteal artery thrombosis treated with streptokinase. Lancet. 1962 Nov 24;2(7265):1081–1083. doi: 10.1016/s0140-6736(62)90786-9. [DOI] [PubMed] [Google Scholar]
  3. FLETCHER A. P., ALKJAERSIG N., SHERRY S. The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J Clin Invest. 1959 Jul;38(7):1096–1110. doi: 10.1172/JCI103886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FOGARTY T. J., CRANLEY J. J., KRAUSE R. J., STRASSER E. S., HAFNER C. D. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet. 1963 Feb;116:241–244. [PubMed] [Google Scholar]
  5. GROSS R., HARTL W., KLOSS G., RAHN B. [Thrombolysis by infusions of highly purified streptokinase. Experience and research on the first 50 patients]. Dtsch Med Wochenschr. 1960 Dec 2;85:2129–2141. doi: 10.1055/s-0028-1112707. [DOI] [PubMed] [Google Scholar]
  6. HAAN D., TILSNER V. FIBRINOLYSE-THERAPIE VON THROMBOSEN UND EMBOLIEN. ERFAHRUNGSBERICHT. Munch Med Wochenschr. 1965 Mar 26;107:638–644. [PubMed] [Google Scholar]
  7. Hiemeyer V., Rasche H., Diehl K. Der Einfluss von Antikoagulantien und Streptokinase auf den Verlauf des akuten Herzinfarktes. Klin Wochenschr. 1969 Apr 1;47(7):371–375. doi: 10.1007/BF01734759. [DOI] [PubMed] [Google Scholar]
  8. KAHN P., STACHER A., DEUTSCH E. [Thrombolytic therapy with highly purified streptokinase]. Wien Klin Wochenschr. 1961 Oct 6;73:677–681. [PubMed] [Google Scholar]
  9. MARCHAL G., SOULIE P., BILSKI PASQUIER G., ABASTADO M., CASTEL A., GOGLIN G., PROST R. J., SAMAMA M. LA TH'ERAPEUTIQUE THROMBOLYTIQUE. ESSAI DE TRAITEMENT PAR LA STREPTOKINASE PURIFI'EE. Arch Mal Coeur Vaiss. 1964 Jul;57:753–772. [PubMed] [Google Scholar]
  10. MCNICOL G. P., REID W., BAIN W. H., DOUGLAS A. S. Treatment of peripheral arterial occlusion by streptokinase perfusion. Br Med J. 1963 Jun 8;1(5344):1508–1512. doi: 10.1136/bmj.1.5344.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Poliwoda H., Alexander K., Buhl V., Holsten D., Wagner H. H. Treatment of chronic arterial occlusions with streptokinase. N Engl J Med. 1969 Mar 27;280(13):689–692. doi: 10.1056/NEJM196903272801304. [DOI] [PubMed] [Google Scholar]
  12. Remy D., Gebauer D. Die fibrinolytische Behandlung des Herzinfarktes. Med Klin. 1966 Feb 11;61(6):220–223. [PubMed] [Google Scholar]
  13. SALMON J., LAMBERT P. H., DELVIGNE J. TRAITEMENT FIBRINOLYTIQUE. SES INDICATIONS, SA SURVEILLANCE, SES R'ESULTATS. Acta Cardiol. 1963;18:254–272. [PubMed] [Google Scholar]
  14. Schmutzler R. Neuere Erkenntnisse der therapeutischen Fibrinolyse. Helv Med Acta. 1963 Nov;30(4):608–614. [PubMed] [Google Scholar]
  15. Schmutzler R. Thrombolytic treatment of acute peripheral arterial and venous occlusions. Angiologica. 1968;5(2):119–129. [PubMed] [Google Scholar]
  16. Schoop W., Martin M., Zeitler E. Beseitigung alter Arterienverschlüsse durch intravenöse Streptokinase-Infusion. Dtsch Med Wochenschr. 1968 Nov 29;93(48):2321–2324. doi: 10.1055/s-0028-1110933. [DOI] [PubMed] [Google Scholar]
  17. VERSTRAETE M., AMERY A., VERMYLEN J. Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. I. Clinical and arteriographic results. Br Med J. 1963 Jun 8;1(5344):1499–1504. doi: 10.1136/bmj.1.5344.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Verstraete M., Vermylen J., Amery A., Vermylen C. Thrombolytic therapy with streptokinase using a standard dosage scheme. Br Med J. 1966 Feb 19;1(5485):454–456. doi: 10.1136/bmj.1.5485.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WINCKELMANN G., HIEMEYER V., WEISSLEDER H., SCHOOP W. DIE THROMBOLYTISCHE BEHANDLUNG MIT STEPTOKINASE BEI AKUTEN ARTERIELLEN VERSCHLUSSKRANKHEITEN. Dtsch Med Wochenschr. 1963 Nov 29;88:2331–2335. doi: 10.1055/s-0028-1112362. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES